查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302260

迴圈腫瘤細胞市場：按檢體、技術、產品和用途- 俄羅斯-烏克蘭衝突、高通貨膨脹的累積影響 - 2023-2030 年全球預測

Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球迴圈腫瘤細胞市場預計到2023年將大幅成長至124.4億美元，複合年成長率為13.97%，預計到2030年將達到驚人的311.2億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球迴圈腫瘤細胞市場至關重要。通過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.迴圈腫瘤細胞的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球迴圈腫瘤細胞市場的抑制要素和影響是什麼？

3.預測期內全球迴圈腫瘤細胞市場需要投資哪些產品/細分市場/應用/領域？

4、全球迴圈腫瘤細胞市場的競爭策略是什麼？

5. 全球迴圈腫瘤細胞市場的技術趨勢和法律規範是什麼？

6.全球迴圈腫瘤細胞市場主要廠商的市場佔有率如何？

7. 哪些型態和戰略舉措可能適合進入全球迴圈腫瘤細胞市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 癌症相關治療的支出增加
      • 世界各地的癌症流行
      • 提高對癌症早期發現的認知和關注
    • 抑制因素
      • 對CTC系統缺乏認知
    • 機會
      • 生物工程和醫學實踐的技術進步
      • 近年來微創診斷的需求
    • 課題
      • CTC技術核准有嚴格的政府法規
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 樣本迴圈腫瘤細胞市場

  • 血
  • 骨髓

第7章 迴圈腫瘤細胞市場：按技術分類

  • CTC分析
  • CTC檢測和富集方法
    • 組合法
    • 基於密度的分離
    • 免疫捕獲
      • 負選擇
      • 正向選擇
    • 根據尺寸分離
      • 基於膜的
      • 基於微流控
  • CTC直接檢測法
    • 顯微鏡檢查
    • SERS

第8章 迴圈腫瘤細胞市場：副產品

  • 採血管
  • 設備或系統
  • 試劑盒和試劑

第9章 迴圈腫瘤細胞市場：按用途

  • 臨床/液體活體組織切片
    • 風險評估
    • 篩查和監測
  • 調查
    • 癌症幹細胞和腫瘤形成的研究
    • 藥物或療法開發

第10章 美洲迴圈腫瘤細胞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太迴圈腫瘤細胞市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲迴圈腫瘤細胞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-A339DAEF9FAB

The Global Circulating Tumor Cell Market is forecasted to grow significantly, with a projected USD 12.44 billion in 2023 at a CAGR of 13.97% and expected to reach a staggering USD 31.12 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Circulating Tumor Cell Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Circulating Tumor Cell Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Specimen, market is studied across Blood and Bone Marrow. The Blood is projected to witness significant market share during forecast period.

Based on Technology, market is studied across CTC Analysis, CTC Detection & Enrichment Methods, and CTC Direct Detection Methods. The CTC Detection & Enrichment Methods is further studied across Combined Methods, Density-Based Separation, Immunocapture, and Size-Based Separation. The Immunocapture is further studied across Negative Selection and Positive Selection. The Size-Based Separation is further studied across Membrane-Based and Microfluidic-Based. The CTC Direct Detection Methods is further studied across Microscopy and SERS. The CTC Direct Detection Methods is projected to witness significant market share during forecast period.

Based on Product, market is studied across Blood Collection Tubes, Devices or Systems, and Kits & Reagents. The Blood Collection Tubes is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical/ Liquid Biopsy and Research. The Clinical/ Liquid Biopsy is further studied across Risk Assessment and Screening & Monitoring. The Research is further studied across Cancer Stem Cell & Tumorigenesis Research and Drug or Therapy Development. The Research is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Circulating Tumor Cell Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Circulating Tumor Cell Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Circulating Tumor Cell Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Circulating Tumor Cell Market?

4. What is the competitive strategic window for opportunities in the Global Circulating Tumor Cell Market?

5. What are the technology trends and regulatory frameworks in the Global Circulating Tumor Cell Market?

6. What is the market share of the leading vendors in the Global Circulating Tumor Cell Market?

7. What modes and strategic moves are considered suitable for entering the Global Circulating Tumor Cell Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Circulating Tumor Cell Market, by Specimen, 2022 vs 2030
  • 4.3. Circulating Tumor Cell Market, by Technology, 2022 vs 2030
  • 4.4. Circulating Tumor Cell Market, by Product, 2022 vs 2030
  • 4.5. Circulating Tumor Cell Market, by Application, 2022 vs 2030
  • 4.6. Circulating Tumor Cell Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased spending in cancer-related therapies
      • 5.1.1.2. Prevalence of cancer across the globe
      • 5.1.1.3. Rising awareness and focus on early cancer detection
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness about CTC systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in bioengineering and biomedical practices
      • 5.1.3.2. Demand for minimally invasive diagnostics in recent years
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for the approval of CTC technologies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Circulating Tumor Cell Market, by Specimen

  • 6.1. Introduction
  • 6.2. Blood
  • 6.3. Bone Marrow

7. Circulating Tumor Cell Market, by Technology

  • 7.1. Introduction
  • 7.2. CTC Analysis
  • 7.3. CTC Detection & Enrichment Methods
    • 7.3.1. Combined Methods
    • 7.3.2. Density-Based Separation
    • 7.3.3. Immunocapture
      • 7.3.3.1. Negative Selection
      • 7.3.3.2. Positive Selection
    • 7.3.4. Size-Based Separation
      • 7.3.4.1. Membrane-Based
      • 7.3.4.2. Microfluidic-Based
  • 7.4. CTC Direct Detection Methods
    • 7.4.1. Microscopy
    • 7.4.2. SERS

8. Circulating Tumor Cell Market, by Product

  • 8.1. Introduction
  • 8.2. Blood Collection Tubes
  • 8.3. Devices or Systems
  • 8.4. Kits & Reagents

9. Circulating Tumor Cell Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical/ Liquid Biopsy
    • 9.2.1. Risk Assessment
    • 9.2.2. Screening & Monitoring
  • 9.3. Research
    • 9.3.1. Cancer Stem Cell & Tumorigenesis Research
    • 9.3.2. Drug or Therapy Development

10. Americas Circulating Tumor Cell Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Circulating Tumor Cell Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Circulating Tumor Cell Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
  • FIGURE 2. CIRCULATING TUMOR CELL MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2022 VS 2030 (%)
  • FIGURE 5. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 7. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CIRCULATING TUMOR CELL MARKET DYNAMICS
  • FIGURE 10. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 5. CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 10. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 14. CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 18. CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 22. CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. CIRCULATING TUMOR CELL MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CIRCULATING TUMOR CELL MARKET SIZE, BY SERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 31. CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 35. CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG OR THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 252. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 253. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 256. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 262. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 263. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 265. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 266. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 272. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 273. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 275. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 276. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 282. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 283. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 285. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 286. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 292. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 293. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 295. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 296. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 302. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 303. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 304. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 305. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 306. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 312. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 313. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
  • TABLE 316. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 322. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 323. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
  • TABLE 325. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY I